Health
-
How young is too young? No such thing, apparently.
Specialist outlines impact of screen time on developing brains, from toddlerhood to teen years
-
When graphic design saves lives
AIDS public health poster collection illustrates communication in a crisis
-
How just a fishing expedition helped lead to GLP-1
Story of game-changing therapy illustrates crucial role of fundamental research breakthroughs
Part of the Profiles of Progress series -
Tracking precisely how learning, memories are formed
Groundbreaking new technique may offer insights for new therapies to treat disorders like dementia
-
Earlier warning on pediatric cancer recurrence
AI tool does a better job predicting relapse risk than traditional methods in Harvard study
-
Worth the grind
Hard work of securing a federal grant pays off for researchers: ‘It means you can do something to try to help people.’
-
‘Endemic’ is not an exit
Harvard’s William Hanage, an epidemiologist and associate professor at the Harvard T.H. Chan School of Public Health, outlines what an endemic SARS-CoV-2 might look like.
-
New genetic insights on common cause of heart attack in younger women
Disruptive variants in genes involved in the production of collagen are implicated in spontaneous coronary artery dissection, a major cause of heart attacks in women under 50.
-
Does nerve damage contribute to long COVID symptoms?
Researchers have learned that nerve damage experienced by some long COVID patients may be caused by infection-triggered immune dysfunction, which is potentially treatable.
-
Sharper vision, sharper mind?
A new study in JAMA Internal Medicine makes a strong case that removing cataracts may reduce your risk for developing dementia.
-
Brain inflammation may strike the uninfected
New study reveals that living through the COVID-19 pandemic may trigger brain inflammation that contributes to fatigue, concentration difficulties, and depression.
-
‘He showed us that the moral high ground can win’
Colleagues mourn the loss of Paul Farmer, Harvard professor and Partners In Health cofounder, and pledge to continue the work he pioneered.
-
The politics behind ineffective COVID treatments
Across the U.S., prescriptions of hydroxychloroquine and ivermectin increased in the latter part of 2020, most significantly in counties with the highest share of people voting Republican.
-
New page in pandemic playbook
Risk assessment experts offer tips for balancing pandemic risks, as government restrictions ease.
-
Hints of a long COVID wave as Omicron fades
As Omicron fades, specialists seek answers for patients who can’t shake symptoms.
-
Study finds significant variations in care between physicians
Some physicians are far more likely to deliver appropriate care than others in the same geographic area or health care system, according to a new study.
-
Push for inclusive language in sciences as part of transgender rights fight
A recent letter addresses the importance of inclusive language in the sciences as part of the ongoing fight for transgender rights
-
Is a mobile app as good as a therapist?
A closer look at the mental health apps that claim to treat depression, anxiety, and other mental illnesses.
-
The COVID treatment that missed its target
“Monoclonal antibodies should first go to patients at the highest risk of death from COVID-19, but the opposite happened …, ” says a Harvard Chan School researcher.
-
Is Omicron really ‘milder’? Not exactly.
The “milder” outcomes of Omicron are likely due to more population immunity rather than the virus’ properties, according to new research.
-
Willing but unable to get COVID shot
Mistrust of vaccine is high among people of color in U.S. and U.K., but unequal access appears to be greater barrier in U.S., researchers say.
-
Research suggests role for anthrax in fighting pain
In search for alternatives to opioids, Medical School researchers have hit on an unlikely candidate.
-
Vitamin D supplements lower risk of autoimmune disease, researchers say
A new study finds vitamin D supplements with or without omega-3s decreased the risk of autoimmune diseases by 22 percent compared to placebo.
-
Hanage and other scientists keep close watch on Omicron subvariant
As Omicron rapidly recedes, some countries are seeing a new version of the variant, dubbed BA.2
-
Race still a factor in air pollution exposure
A new Harvard study has found that racial, ethnic minorities, and low-income groups in U.S. are exposed to higher levels of air pollution.
-
Study explores possible autism link in young adults treated for addiction
One in five youths with substance-use disorders may have undiagnosed autistic traits, say researchers.
-
Exploring why some remain sharp even as decades roll by
Harvard researchers study “super-aging” minds for clues to possible interventions for the rest of us.
-
Comparison of male, female classroom behavior reveals assertiveness gap
A new study finds that women and men physicians participate differently in academic settings, potentially contributing to gender biases that disadvantage female students.
-
How the pandemic may affect baby’s brain
For babies born during this pandemic, a study published in JAMA Pediatrics suggests their brains may not fully develop.
-
Omicron optimism and shift from pandemic to endemic
With Omicron on the decline in some states, pandemic experts permit themselves hope, at least for the near term.
-
Why do more men die of COVID? It’s likely not what you think
Sex differences in COVID death rates vary by state and across time, suggesting social factors play a role.
-
Delta danger in pregnancy scrutinized
Researchers detect the COVID-19 variant in the blood and placentas of women who had stillbirths and pregnancy complications.
-
Add olive oil to cut risk of early death, study suggests
Harvard Chan School researchers see impact in cardiovascular and respiratory conditions, cancer, and neurodegenerative disease.
-
Epstein-Barr virus may be leading cause of MS
Multiple sclerosis is likely caused by infection with the Epstein-Barr virus, according to a study led by Harvard T.H. Chan School of Public Health researchers.
-
Study identifies potential test for cannabis impairment
Researchers have found a noninvasive brain imaging procedure to be an objective and reliable way to identify individuals whose performance has been impaired by THC.
-
Healthy? Maybe. But are you flourishing?
Researchers at Harvard, Baylor launch groundbreaking Global Flourishing Study.